As described above, dexmedetomidine is already in extensive use in the ICU in ventilated patients and in surgery as an anesthetic, and can help diminish delirium in vulnerable subjects [44, 163, 165, 187], including recent data using α2-AR agonists to treat delirium associated with acute COVID-19 infection [188]. This evidence concerns the gene ADORA2A and delirium.